您的位置: 首页 > 农业专利 > 详情页

Methods of using SMAD7 antisense oligonucleotides
专利权人:
Celgene Alpine Investment Company II; LLC
发明人:
Smith, Scott Andrew,Li, Xiaobin,Rossiter, Guillermo,Martin, Philippe L.,Dewacker, Seth R.,Usiskin, Keith,Cline, Gary Allan
申请号:
AU2015371325
公开号:
AU2015371325A1
申请日:
2015.12.23
申请国别(地区):
AU
年份:
2017
代理人:
摘要:
Described herein are methods of treating inflammatory bowel disease (I BD) in a patient having IBD using SMAD7 antisense oligonucleotides. In one aspect, provided herein is a method for treating or managing inflammatory bowel disease (IBD) in a patient having IBD, wherein the method comprises (a) administering to the patient a SMAD7 antisense-oligonucleotide (SMAD7 AON) during a first treatment period at a first dose; and (b) administering to the patient the SMAD7 antisense-oligonucleotide during a second treatment period at a second dose.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充